Epstein-Barr virus nuclear antigen-1 B-cell epitopes in multiple sclerosis twins

Area of Science:

• Immunology
• Virology
• Neurology

Background:

• Qualitative immune responses to Epstein-Barr virus (EBV) in multiple sclerosis (MS) are less studied than quantitative ones.
• EBV is a potential factor in MS pathogenesis, but specific immune targets require further investigation.

Purpose of the Study:

• To investigate B-cell epitopes of antibodies against Epstein-Barr nuclear antigen-1 (EBNA-1).
• To determine the relevance of EBNA-1 antibodies for multiple sclerosis (MS) pathogenesis using a twin study design.

Main Methods:

• Evaluated antibodies to EBNA-1 octapeptides in 12 monozygotic twin pairs (9 MS-discordant, 3 healthy) and other subjects.
• Utilized enzyme-linked immunosorbent assay (ELISA) kits for EBV serology and antibodies against specific EBNA-1 peptides.
• Assessed immune response to immunodominant glycine-alanine rich domain and other EBNA-1 epitopes.

Main Results:

• The glycine-alanine rich domain of EBNA-1 was immunodominant across all study participants.
• Affected co-twins and non-twin MS patients exhibited a significantly increased antibody response to an EBNA-1 epitope (aa. 401-411) compared to healthy individuals.
• This heightened response to the specific EBNA-1 epitope was similar to findings in infectious mononucleosis (IM) patients.

Conclusions:

• The study identifies a specific EBNA-1 antibody epitope associated with MS.
• This EBNA-1 specificity may play a role in the pathogenesis of multiple sclerosis.
• Findings from this controlled study provide a focused target for understanding MS-EBV interactions.